Solvay Valuation

Is SOLBB undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of SOLBB when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: SOLBB (€30.64) is trading below our estimate of fair value (€53.35)

Significantly Below Fair Value: SOLBB is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for SOLBB?

Key metric: As SOLBB is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for SOLBB. This is calculated by dividing SOLBB's market cap by their current revenue.
What is SOLBB's PS Ratio?
PS Ratio0.6x
Sales€5.22b
Market Cap€3.25b

Price to Sales Ratio vs Peers

How does SOLBB's PS Ratio compare to its peers?

The above table shows the PS ratio for SOLBB vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average1.2x
JMAT Johnson Matthey
0.2x-50.4%UK£2.5b
CRDA Croda International
3x5.1%UK£4.9b
NLMK Novolipetsk Steel
0.3xn/aUS$4.1b
ELM Elementis
1.3x3.4%UK£776.9m
SOLBB Solvay
0.6x0.2%€3.2b

Price-To-Sales vs Peers: SOLBB is good value based on its Price-To-Sales Ratio (0.6x) compared to the peer average (1.5x).


Price to Sales Ratio vs Industry

How does SOLBB's PS Ratio compare vs other companies in the GB Chemicals Industry?

6 CompaniesPrice / SalesEstimated GrowthMarket Cap
JMAT Johnson Matthey
0.2x-50.4%US$3.20b
SYNT Synthomer
0.1x5.0%US$338.95m
CAR Carclo
0.2x7.0%US$32.05m
HEIQ HeiQ
0.2xn/aUS$9.61m
No. of Companies6PS01.22.43.64.86+
6 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: SOLBB is good value based on its Price-To-Sales Ratio (0.6x) compared to the UK Chemicals industry average (1.3x).


Price to Sales Ratio vs Fair Ratio

What is SOLBB's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

SOLBB PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.6x
Fair PS Ration/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate SOLBB's Price-To-Sales Fair Ratio for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst SOLBB forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€30.64
€33.19
+8.3%
12.9%€40.00€26.00n/a16
Nov ’25n/a
€32.63
0%
13.9%€40.00€24.00n/a16
Oct ’25n/a
€31.94
0%
12.8%€40.00€24.00n/a16
Sep ’25€31.19
€31.63
+1.4%
13.3%€40.00€24.00n/a16
Aug ’25€31.24
€32.16
+2.9%
13.5%€40.00€24.00n/a16
Jul ’25n/a
€39.28
0%
73.6%€150.00€24.00n/a16
Jun ’25€33.72
€39.28
+16.5%
73.6%€150.00€24.00n/a16
May ’25n/a
€37.25
0%
79.5%€150.00€20.00n/a16
Apr ’25n/a
€36.22
0%
82.4%€150.00€20.00n/a16
Mar ’25n/a
€36.16
0%
82.7%€150.00€20.00n/a16
Feb ’25n/a
€47.44
0%
82.4%€150.00€22.00n/a16
Jan ’25n/a
€75.20
0%
69.5%€150.00€22.00n/a15
Dec ’24€106.30
€125.53
+18.1%
16.3%€155.00€84.00n/a15
Nov ’24n/a
€126.86
0%
15.5%€155.00€84.00n/a17
Oct ’24€103.43
€127.74
+23.5%
15.2%€155.00€84.00n/a17
Sep ’24n/a
€125.53
0%
16.2%€155.00€84.00€31.1917
Aug ’24n/a
€125.18
0%
16.3%€155.00€84.00€31.2417
Jul ’24€100.50
€124.06
+23.4%
15.9%€150.00€84.00n/a16
Jun ’24€98.76
€122.33
+23.9%
16.0%€150.00€84.00€33.7215
May ’24€106.50
€121.53
+14.1%
16.1%€150.00€81.00n/a15
Apr ’24€105.40
€121.53
+15.3%
16.1%€150.00€81.00n/a15
Mar ’24€107.90
€117.73
+9.1%
15.1%€145.00€81.00n/a15
Feb ’24€108.50
€115.80
+6.7%
16.3%€145.00€81.00n/a15
Jan ’24n/a
€112.00
0%
16.8%€145.00€81.00n/a16
Dec ’23€93.03
€112.00
+20.4%
16.8%€145.00€81.00€106.3016
Nov ’23€91.66
€108.88
+18.8%
16.8%€145.00€71.00n/a17

Analyst Forecast: Target price is less than 20% higher than the current share price.


Discover undervalued companies